When the Filter Breaks — Renal AA Amyloidosis

The Story

Here is the diagnosis the whole course has been pointing at. For years Stina’s untreated FMF kept her inflammation high, and chronic inflammation drives the liver to overproduce serum amyloid A (SAA), an acute-phase protein. SAA is meant to rise and fall with inflammation, but when it stays high for years, its fragments misfold into insoluble fibrils — AA amyloid — that deposit in tissues. The kidney, with its enormous blood flow and its delicate glomerular barrier, is the favorite landing site. Amyloid fibrils accumulate in the glomeruli, infiltrating and disrupting that three-layer filtrationThe process by which fluid moves out of capillaries into surrounding tissues due to hydrostatic pre barrier — battering the basement membrane and the podocyte slits until the sieve can no longer hold protein back. A biopsy confirms it the classic way: amyloid binds Congo red and glows apple-green under polarizedA resting neuron’s membrane with a more negative charge inside than outside. light. This is renal AA amyloidosis, and it is the defining, life-threatening complication of untreated FMF.

With the broken barrier in view, two ideas snap into focus. First, the kind of proteinuria tells you where the kidney is failing. Glomerular proteinuria — Stina’s kind — is a leak of large proteinsLarge molecules made of amino acids with various functions in the body. like albuminA plasma protein that helps maintain osmotic pressure and transport substances. through a damaged filter, and it can climb into the heavy, nephrotic range with the low blood albumin, edemaExcess fluid in interstitial spaces., and risk that nephrotic syndrome brings. Tubular proteinuria is different: it is a smaller leak of low-molecular-weight proteins that the damaged tubule failed to reabsorb, and it stays modest. Distinguishing the two localizes the disease — and Stina’s heavy, albumin-rich, biopsy-confirmed leak is unmistakably glomerular. Second, and most important, this is treatable at its root. Amyloid is fed by SAA, and SAA is fed by inflammation, so the cure is to shut the inflammation down. Colchicine, taken faithfully, suppresses the FMF attacks and lowers SAA, starving the amyloid of its raw material and halting — even partially reversing — its depositionThe process of bone matrix formation by osteoblasts.. This is why colchicine adherence is no longer about pain; for Stina it is about whether her kidneys survive. The drug that controlled her attacks is now the drug that protects her life, a thread that runs straight into the capstone (M21).

From Stina’s chart: Stina’s renal biopsy is read as AA-type amyloid deposited in the glomeruli, staining positive with Congo red and showing apple-green birefringence under polarized light; her proteinuria is nephrotic-range, and the report names renal AA amyloidosis — the defining complication of untreated FMF.